Encompass Health Co. (NYSE:EHC) Shares Bought by PNC Financial Services Group Inc.

PNC Financial Services Group Inc. lifted its position in shares of Encompass Health Co. (NYSE:EHC - Free Report) by 14.7% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 44,017 shares of the company's stock after acquiring an additional 5,647 shares during the quarter. PNC Financial Services Group Inc.'s holdings in Encompass Health were worth $4,254,000 as of its most recent SEC filing.

Other institutional investors have also recently modified their holdings of the company. UMB Bank n.a. boosted its holdings in Encompass Health by 387.7% in the 3rd quarter. UMB Bank n.a. now owns 317 shares of the company's stock worth $31,000 after buying an additional 252 shares during the last quarter. V Square Quantitative Management LLC boosted its holdings in shares of Encompass Health by 53.0% during the 3rd quarter. V Square Quantitative Management LLC now owns 404 shares of the company's stock worth $39,000 after purchasing an additional 140 shares during the last quarter. Oakworth Capital Inc. acquired a new stake in shares of Encompass Health in the second quarter valued at approximately $40,000. Benjamin F. Edwards & Company Inc. lifted its position in Encompass Health by 58.9% during the second quarter. Benjamin F. Edwards & Company Inc. now owns 534 shares of the company's stock worth $46,000 after buying an additional 198 shares in the last quarter. Finally, Point72 Asia Singapore Pte. Ltd. acquired a new position in Encompass Health during the second quarter worth $58,000. 97.25% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Several research firms recently issued reports on EHC. KeyCorp raised their price objective on shares of Encompass Health from $115.00 to $117.00 and gave the stock an "overweight" rating in a research report on Tuesday, October 29th. Royal Bank of Canada increased their price objective on Encompass Health from $105.00 to $110.00 and gave the stock an "outperform" rating in a research report on Wednesday, October 30th. Stephens reiterated an "overweight" rating and set a $105.00 price target on shares of Encompass Health in a research report on Tuesday, August 6th. UBS Group increased their price objective on shares of Encompass Health from $100.00 to $110.00 and gave the stock a "buy" rating in a research report on Wednesday, September 25th. Finally, Truist Financial reissued a "buy" rating and issued a $116.00 target price (up previously from $108.00) on shares of Encompass Health in a research report on Wednesday, October 30th. Nine research analysts have rated the stock with a buy rating and two have given a strong buy rating to the stock. According to MarketBeat.com, Encompass Health currently has an average rating of "Buy" and an average price target of $107.11.

Encompass Health Stock Up 0.9 %

Shares of EHC traded up $0.88 during midday trading on Monday, hitting $102.00. The company had a trading volume of 768,391 shares, compared to its average volume of 642,760. The company's 50-day simple moving average is $97.28 and its 200-day simple moving average is $90.99. The firm has a market capitalization of $10.28 billion, a P/E ratio of 24.64, a P/E/G ratio of 1.34 and a beta of 0.88. Encompass Health Co. has a 1 year low of $63.78 and a 1 year high of $104.55. The company has a debt-to-equity ratio of 0.88, a quick ratio of 1.04 and a current ratio of 1.04.

Encompass Health (NYSE:EHC - Get Free Report) last announced its quarterly earnings data on Monday, October 28th. The company reported $1.03 earnings per share for the quarter, beating analysts' consensus estimates of $0.94 by $0.09. The business had revenue of $1.35 billion for the quarter, compared to analyst estimates of $1.33 billion. Encompass Health had a net margin of 8.10% and a return on equity of 17.60%. The company's revenue was up 11.9% on a year-over-year basis. During the same period last year, the business earned $0.86 EPS. As a group, sell-side analysts expect that Encompass Health Co. will post 4.29 EPS for the current year.

Encompass Health Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Wednesday, January 15th. Stockholders of record on Thursday, January 2nd will be issued a $0.17 dividend. This represents a $0.68 annualized dividend and a dividend yield of 0.67%. The ex-dividend date is Thursday, January 2nd. Encompass Health's payout ratio is 16.43%.

Encompass Health Company Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.